Jfs Wealth Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

Jfs Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$26.32 - $34.31 $526 - $686	20 Added 2000.0%	21 $0
Q3 2023 Nov 02, 2023	SELL	$30.68 - $40.09 $490 - $641	-16 Reduced 94.12%	1 $0
Q2 2023 Aug 07, 2023	SELL	$36.12 - $47.5 $144 - $190	-4 Reduced 19.05%	17 $0
Q1 2023 Apr 19, 2023	BUY	$35.53 - $43.38 $106 - $130	3 Added 16.67%	21 $0
Q4 2022 Feb 13, 2023	BUY	$38.19 - $57.45 $381 - $574	10 Added 125.0%	18 $0
Q3 2022 Oct 21, 2022	SELL	$51.24 - $58.89 $204 - $235	-4 Reduced 33.33%	8 $0
Q2 2022 Aug 02, 2022	SELL	$51.49 - $81.64 $154 - $244	-3 Reduced 20.0%	12 $1,000
Q1 2022 May 02, 2022	BUY	$60.03 - $76.49 $540 - $688	9 Added 150.0%	15 $1,000
Q4 2021 Feb 03, 2022	BUY	$47.97 - $62.21 $287 - $373	6 New	6 $0

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.